Breaking Resistance: Role of Nitric Oxide in the Sensitization of Cancer Cells to Chemo- and immunotherapy
- 8 April 2010
- book chapter
- Published by Springer Nature
- p. 283-290
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Novel therapeutic applications of nitric oxide donors in cancer: Roles in chemo- and immunosensitization to apoptosis and inhibition of metastasesNitric Oxide, 2008
- Regulation of apoptosis-related genes by nitric oxide in cancerNitric Oxide, 2008
- Nitric oxide induces CD4+CD25+Foxp3−regulatory T cells from CD4+CD25−T cells via p53, IL-2, and OX40Proceedings of the National Academy of Sciences, 2007
- Role of TGF-β1 and nitric oxide in the bystander response of irradiated glioma cellsOncogene, 2007
- Randomized Phase II Trial Comparing Nitroglycerin Plus Vinorelbine and Cisplatin With Vinorelbine and Cisplatin Alone in Previously Untreated Stage IIIB/IV Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2006
- Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosationBiochemical and Biophysical Research Communications, 2005
- Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic interventionOncogene, 2005
- Nitric Oxide Disrupts H2O2-dependent Activation of Nuclear Factor κBJournal of Biological Chemistry, 2001
- NO at workCell, 1994
- Macrophage Cytotoxicity: Role for L-Arginine Deiminase and Imino Nitrogen Oxidation to NitriteScience, 1987